Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Oncogene|April 19, 2011
SPG20, a novel biomarker for early detection of colorectal cancer, encodes a regulator of cytokinesisG E Lind, C Raiborg, S A Danielsen, et al.
Plos One|September 13, 2011
Phospholipase C isozymes are deregulated in colorectal cancer--insights gained from gene set enrichment analysis of the transcriptomeStine A Danielsen, Lina Cekaite, Trude H Ågesen, et al.
Molecular Oncology|May 31, 2017
Drug sensitivity and resistance testing identifies PLK1 inhibitors and gemcitabine as potent drugs for malignant peripheral nerve sheath tumorsMatthias Kolberg, Jarle Bruun, Astrid Murumägi, et al.
Clinical and Translational Gastroenterology|January 18, 2013
A tissue-based comparative effectiveness analysis of biomarkers for early detection of colorectal tumorsDeeqa Ahmed, Stine A Danielsen, Trude H Aagesen, et al.
Neoplasia (New York, N.Y.)|September 29, 2012
MiR-9, -31, and -182 deregulation promote proliferation and tumor cell survival in colon cancerLina Cekaite, Juha K Rantala, Jarle Bruun, et al.
ESMO Open|July 20, 2019
Exploratory analyses of consensus molecular subtype-dependent associations of TP53 mutations with immunomodulation and prognosis in colorectal cancerJørgen Smeby, Anita Sveen, Christian H Bergsland, et al.
Cellular Signalling|September 15, 2012
NEDD4 is overexpressed in colorectal cancer and promotes colonic cell growth independently of the PI3K/PTEN/AKT pathwayPeter W Eide, Lina Cekaite, Stine A Danielsen, et al.
Neuro-Oncology|July 20, 2014
Methylated RASSF1A in malignant peripheral nerve sheath tumors identifies neurofibromatosis type 1 patients with inferior prognosisStine A Danielsen, Guro E Lind, Matthias Kolberg, et al.
Oncogenesis|May 17, 2019
Transcriptional and functional consequences of TP53 splice mutations in colorectal cancerJørgen Smeby, Anita Sveen, Ina A Eilertsen, et al.
International Journal of Cancer|May 26, 2017
CpG island methylator phenotype identifies high risk patients among microsatellite stable BRAF mutated colorectal cancersHege Marie Vedeld, Marianne Merok, Marine Jeanmougin, et al.
Pageof 5